CTL escape - Progress in identifying therapeutic avenues to control HIV viraemia

CTL escape - Progress in identifying therapeutic avenues to control HIV viraemia

The central role of HIV-specific cellular immunity in controlling HIV replication is now established. Knowledge of how the virus in the majority of infected persons successfully evades these immune responses is critical to vaccine design. Virus escape from recognition by HIV-specific cytotoxic T-lym...

Full description

Bibliographic Details
Main Author:	Goulder, P
Format:	Journal article
Language:	English
Published:	2000

Similar Items

HIV and SIV CTL escape: implications for vaccine design.
by: Goulder, P, et al.
Published: (2004)

HIV CTL escape: at what cost?
by: Smith Stephen M
Published: (2004-05-01)

Evolution and transmission of stable CTL escape mutations in HIV infection.
by: Goulder, P, et al.
Published: (2001)

Control of HIV viraemia is not enough in perinatal HIV
by: Caroline Foster, et al.
Published: (2015-07-01)

Broad CTL Response in Early HIV Infection Drives Multiple Concurrent CTL Escapes.
by: Sivan Leviyang, et al.
Published: (2015-10-01)

CTL escape and viral fitness in HIV/SIV infection
by: Sayuri eSeki, et al.
Published: (2012-01-01)

Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag.
by: Carlson, J, et al.
Published: (2008)

HIV evolution: CTL escape mutation and reversion after transmission.
by: Leslie, A, et al.
Published: (2004)

Structured observations reveal slow HIV-1 CTL escape
by: Roberts, H, et al.
Published: (2015)

Structured observations reveal slow HIV-1 CTL escape.
by: Hannah E Roberts, et al.
Published: (2015-02-01)

Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag.
by: Jonathan M Carlson, et al.
Published: (2008-11-01)

HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.
by: Feeney, M, et al.
Published: (2005)

Genetic diversity and CTL escape burden in the replication-competent HIV reservoir in youth in a therapeutic HIV vaccine trial
by: Z.L. Brumme, et al.
Published: (2017-12-01)

Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection.
by: Vitaly V Ganusov, et al.
Published: (2006-03-01)

CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
by: Sylvain Cardinaud, et al.
Published: (2011-05-01)

Impact of transmitted CTL escape mutations on replicative capacity and HIV pathogenesis in early infection
by: Prince J, et al.
Published: (2012-09-01)

HIV-2 gene product-specific T cell responses and viraemia control
by: Njai Harr, et al.
Published: (2006-12-01)

HIV-2 gene product-specific T cell responses and viraemia control
by: Leligdowicz, A, et al.
Published: (2006)

Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation.
by: Goulder, P, et al.
Published: (2001)

Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.
by: Ganusov, V, et al.
Published: (2011)

Cw*0303/0304 HIV specific CTL response toward GagYL9 select for HIV escape variants with low fitness that is compensated by intra-codon variation
by: Honeyborne, I, et al.
Published: (2009)

Escape from immune control by HIV
by: McMichael, A, et al.
Published: (1997)

Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
by: Karlsson, A, et al.
Published: (2007)

Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape
by: Karlsson, A, et al.
Published: (2007)

Within-Epitope Interactions Can Bias CTL Escape Estimation in Early HIV Infection
by: Victor Garcia, et al.
Published: (2017-05-01)

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
by: Ryan M Troyer, et al.
Published: (2009-04-01)

HIV escape and attenuation by cytotoxic T lymphocytes.
by: Leslie, A, et al.
Published: (2006)

CTL epitope escape and reversion in acute HCV infection.
by: Timm, J, et al.
Published: (2004)

Immune Activation and HIV-1 Viraemia In an Asymptomatic Paediatric Patient
by: Zaknun D., et al.
Published: (1994-11-01)

Kinetics of HIV-Specific CTL Responses Plays a Minimal Role in Determining HIV Escape Dynamics
by: Yiding Yang, et al.
Published: (2018-02-01)

Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.
by: Leslie, A, et al.
Published: (2005)

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication
by: Altfeld M, et al.
Published: (2009-10-01)

CTL escape viral variants. I. Generation and molecular characterization.
by: Lewicki, H, et al.
Published: (1995)

P09-18. Cw 0303/0304 HIV specific CTL response toward GagYL9 select for HIV escape variants with low fitness that is compensated by intra-codon variation
by: Honeyborne, I, et al.
Published: (2009)

P09-18. Cw*0303/0304 HIV specific CTL response toward GagYL9 select for HIV escape variants with low fitness that is compensated by intra-codon variation
by: Walker BD, et al.
Published: (2009-10-01)

Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.
by: Denis R Chopera, et al.
Published: (2008-03-01)

CTL Escape and Codon Covariation in Subtypes B and C p17 (Matrix) and p24 (Capsid) Proteins
by: Carlson, J, et al.
Published: (2008)

Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.
by: Jens Dinter, et al.
Published: (2015-03-01)

Quantifying factors determining the rate of CTL escape and reversion during acute and chronic phases of HIV infection
by: Ganusov, V, et al.
Published: (2010)

20 Rapid CTL recognition of HIV-1 latently infected cells depends on the levels of inducible viral reactivation and CTL activation status
by: A. Ruiz, et al.
Published: (2017-07-01)